• Considerations for Researchers: COVID-19 RISK and (Re)Consent
• Guidance for C&W researchers during the curtailment period
• UBC guidance for using zoom for research
• Electronic Informed Consent (e-consent) Guidance
• Guidance for C&W researchers working from home

‎Check back regularly for REB news and updates.

To enable researchers to secure funding from the US Department of Health and Human Services (DHHS), the UBC C&W REB and the Children's & Women's Health Centre of British Columbia have obtained OHRP Federal-wide Assurance (FWA) and Institutional Review Board (IRB) Assurance.

Every institution engaged in human subjects research supported or conducted by the US DHHS is required, under the DHHS human subjects protection regulations (45 CFR 46.103), to have an assurance of compliance approved by the US Office for Human Research Protections (OHRP).

See also the C&W REB Assurance of Compliance.

OHRP has launched a webpage with information on the revised Common Rule’s clinical trial informed consent form posting requirement (45 CFR 46.116(h)). Please send questions or comments about the revised posting requirement to OHRP@hhs.gov.

 The UBC C&W REB meets on the 4th Wednesday of each month, with the exception of the December meeting, which will take place on the 2nd Wednesday of the month.

The deadlines for full board review are listed below. Please note that there is no deadline for Minimal Risk studies.

Submissions must be received by 4:30 p.m. on the due date. Researchers are required to have their completed ethics application - including departmental approval - submitted to the UBC C&W REB prior to the submission deadline. Any submissions received after this time will be reviewed at the following month's meeting.

It is the Principal Investigator's responsibility to ensure that their department head has been notified of the application and ensure that departmental approval has been received prior to the deadline for submission. Departmental approval occurs electronically following Principal Investigator sign off on the application.

2024 Deadlines                                                              2025 Meetings

November 27                                                                   December 11

There are two types of fees: 1) initial review and 2) annual renewal. The fees only apply to sponsored studies that are in whole or in part from a for-profit entity. Please refer to the C&W REB Fee Policy (PDF) which contains information on:

• Definition of a for-profit sponsored study
  
• Fee waiver criteria
  
• Initial review fees
  
• Annual review fees
  
• Fee payment information
  

The UBC C&W REB Office will issue an invoice in RISe once your research project has been submitted. Note that the Certificate of Approval will not be released until the review fee has been received.

The UBC C&W REB Office will issue an invoice once your renewal post approval activity (PAA) has been submitted on RISe. Note that the Renewal Certificate of Approval will not be released until the review fee has been received. If an application expires pending renewal, it will stay in the expired state until the review fee has been paid and the certificate has been released. 

Note that if you have outstanding fees, no new REB reviews will be undertaken and no approvals will be processed until your account is brought into good standing.

‎

Please note that the REB staff are currently on-site one day per week and are otherwise working remotely.  Please email us and we will be happy to set up a time for a phone call or meeting.  

The C&W REB will be offering online drop-in sessions on the first and third Thursday of the month. Please email the REB for the upcoming session link. 

Jennie Prasad, Director

Jennie oversees the functioning of the REB staff and Board, monitors ethical review process standards, and advises on compliance with ethics policies. 

Email Jennie

Farin Meralli, Research Ethics & Regulatory Specialist

Farin is responsible for the review of new full-board and minimal risk applications and associated deferral/proviso responses and general inquiries. 

Email Farin

Talysa Dhahan, Research Ethics & Regulatory Analyst

Talysa is responsible for the review of new minimal risk applications and associated deferral/proviso responses and general inquiries. 

Email Talysa

Manisha Sangha, Administrative Coordinator  

Manisha is responsible for handling incoming general inquiries, post-approval activities, institutional approvals, and fee payment.

Mailing Address & General Contact Information

UBC Children's & Women’s Research Ethics Board

Room A2-141A

950 West 28th Avenue

Vancouver, BC V5Z 4H4

CANADA

Phone: 604-875-3103

Email C&W REB

Fax: 604-875-2496